Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

123.12
Delayed Data
As of May 22
 +1.19 / +0.98%
Today’s Change
13.09
Today|||52-Week Range
154.75
+34.13%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 165.50, with a high estimate of 210.00 and a low estimate of 130.00. The median estimate represents a +34.42% increase from the last price of 123.12.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.64
Sales
$0.00
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -42.59%
 
 
 
 
 
 
Growthannually -6.82%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.